Research Analysis: Use Neuromodulation for CRPS Sooner not Later

A research analysis published in Neuromodulation: Technology at the Neural Interface concluded that clinicians should consider spinal cord stimulation (SCS) earlier than as a last resort for the treatment of complex regional pain syndrome (CRPS).  SCS has been FDA-approved for the treatment of neuropathic trunk and limb pain since 1989 and involves a slender electrical lead implanted under the skin of the back to deliver a mild electrical current to the spinal cord. The analysis found that to facilitate functional rehabilitation in CRPS, SCS should be considered as soon as more conservative therapies have failed – after perhaps three months. Read a news report here.

Posted on August 4, 2013

Related Content

• Osteoblasts May Help Bone Loss Therapy for Osteoporosis
• EAET: Emotional Awareness and Expression Therapy for Fibromyalgia Pain
• PAINWeek Scholarship
• Why Breast Cancer Patients on Opioids Avoid Life-Prolonging Therapy
• HHS Task Force to Help "Handle the Serious Problem of Pain in America"
• Peripheral Neuropathy After Chemotherapy: An Underappreciated Risk?
• Interprofessional Education for Pain Practitioners
• Treating Osteoarthritis Pain: Emerging Therapies and the Future
• Opioid Overdose Vaccine: Helping the Substance Use Disorder Epidemic
• CDC Prescribing Guidelines: Federal Review is Biased and Inconsistent